These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25895585)

  • 1. Impact of global versus renal-specific sympathoinhibition in aldosterone-induced hypertension: implications for medical device-based treatment of resistant hypertension.
    Carmichael CY; Wainford RD
    Hypertension; 2015 Jun; 65(6):1160-2. PubMed ID: 25895585
    [No Abstract]   [Full Text] [Related]  

  • 2. Global- and renal-specific sympathoinhibition in aldosterone hypertension.
    Lohmeier TE; Liu B; Hildebrandt DA; Cates AW; Georgakopoulos D; Irwin ED
    Hypertension; 2015 Jun; 65(6):1223-30. PubMed ID: 25895584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of nifedipine on effective renal plasma flow, plasma renin activity and serum aldosterone, noradrenaline and adrenaline levels in healthy persons and in patients with primary moderate arterial hypertension].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):707-9. PubMed ID: 2701747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
    Dorresteijn JA; Schrover IM; Visseren FL; Scheffer PG; Oey PL; Danser AH; Spiering W
    J Hypertens; 2013 Feb; 31(2):393-403. PubMed ID: 23235355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
    Lincevicius GS; Shimoura CG; Nishi EE; Perry JC; Casarini DE; Gomes GN; Bergamaschi CT; Campos RR
    Am J Hypertens; 2015 Sep; 28(9):1083-90. PubMed ID: 25628418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged activation of the baroreflex abolishes obesity-induced hypertension.
    Lohmeier TE; Dwyer TM; Irwin ED; Rossing MA; Kieval RS
    Hypertension; 2007 Jun; 49(6):1307-14. PubMed ID: 17438305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
    Klotz S; Burkhoff D; Garrelds IM; Boomsma F; Danser AH
    Eur Heart J; 2009 Apr; 30(7):805-12. PubMed ID: 19223317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY; Thibonnier M; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic potentiation of vasoconstrictor hypertension by adrenocorticotropic hormone.
    Lohmeier TE; Carroll RG
    Hypertension; 1982; 4(3 Pt 2):138-48. PubMed ID: 6279499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin-angiotensin-aldosterone system.
    Alvarez-Alvarez B; Abad-Cardiel M; Fernandez-Cruz A; Martell-Claros N
    J Hypertens; 2010 Nov; 28(11):2329-35. PubMed ID: 20651602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The renin-angiotensin-aldosterone system and the adrenergic system in normal pregnancy and hypertension induced by pregnancy].
    Fiévet P; Coevoet B; Andrejak M; Comoy E; Legrand J; Lalau JD; Gheerbrand JD; Boulanger JC; Fournier A
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():95-9. PubMed ID: 6810837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches in the treatment of hypertension.
    Oparil S; Schmieder RE
    Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension].
    Wang L; Lu CZ; Zhang X; Luo D; Zhao B; Yu X; Xia DS; Chen X; Zhao XD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jan; 41(1):3-7. PubMed ID: 23651959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurohumoral response to sublingual captopril and nifedipine in hypertensive emergencies and during the cold test. Contribution to the study of the interaction between the sympathetic and renin-angiotensin systems and atrial natriuretic factor].
    Polónia JJ; Pedro-Nunes J; da Silva MV; Esteves AP; Cunha ME; Brandão FA; Gomes MC
    Rev Port Cardiol; 1988; 7(4):389-98. PubMed ID: 2978843
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.